Source comparison
TB-500 Wound Healing Protocol Dosage Timing: Acute vs Maintenance Phases
The standard TB-500 wound healing protocol dosage timing follows a biphasic structure: acute loading (weeks 1–4) and maintenance dosing (weeks 5 onward). During the acute phase, 2–5mg injections are administered subcutaneously twice weekly. Typically Monday/Th
This comparison does not assign a generated winner or score.
- The standard TB-500 wound healing protocol dosage timing follows a biphasic structure: acute loading (weeks 1–4) and maintenance dosing (weeks 5 onward). During the acute phase, 2–5mg injections are administered subcutaneously twice weekly. Typically Monday/Thursday or Tuesday/Friday to maintain approximately 72-hour intervals between doses. This frequency aligns with TB-500's peak beta-actin upregulation window, which occurs 48–72 hours post-injection and declines thereafter.
- After four weeks, most protocols transition to once-weekly maintenance dosing at 2–3mg per injection. The rationale: by week 4, new capillary networks have formed, collagen deposition has stabilised, and the wound has entered the remodelling phase, where cellular turnover is slower and less migratory activity is needed. Continuing twice-weekly dosing beyond this point offers diminishing returns. The tissue repair machinery is no longer rate-limited by cell migration speed.
- Here's the honest answer: front-loading matters more than total cumulative dose. A protocol using 4mg twice weekly for three weeks (24mg total) will outperform a protocol using 6mg once weekly for four weeks (24mg total) in terms of wound closure speed and tensile strength at day 21. The twice-weekly schedule keeps plasma levels above the threshold required to sustain VEGF upregulation continuously, whereas once-weekly dosing creates peaks and troughs that allow angiogenesis to stall between injections.
- Our experience shows that researchers who skip the front-loading phase and start directly with maintenance dosing consistently report slower healing outcomes. TB-500's effects are cumulative, but the early days post-injury are when migratory speed matters most. Waiting until week 2 to start dosing means you've already missed the proliferative phase's opening window.